9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 8, 2026
9 Meters Biopharma Market Cap
9 Meters Biopharma has a market cap or net worth of $14 as of January 9, 2026. Its market cap has decreased by -99.03% in one year.
Market Cap
14.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 2, 2018, 9 Meters Biopharma's market cap has decreased from 125.90M to 14.00, a decrease of -100.00%. That is a compound annual growth rate of -86.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 14.00 | - |
| Dec 31, 2025 | 14.00 | - |
| Dec 31, 2024 | 14.00 | - |
| Dec 29, 2023 | 14.00 | -100.00% |
| Dec 30, 2022 | 16.32M | -93.48% |
| Dec 31, 2021 | 250.22M | 43.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |